| Title | CNS Drugs |
| Standard Abbreviation | CNS Drugs |
| Type of Publication | Journal |
| Discipline | Neurology (clinical) (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1) |
| Impact Score | 5.69 |
| SCImago Journal Rank (SJR) | 1.485 |
| h-index | 122 |
| Overall Rank | 2173 |
| Publisher Name | Adis International Ltd |
| Publication Country | United Kingdom |
| International Standard Serial Number (ISSN) | 11791934, 11727047 |
| Coverage and History | 1994-2022 |
| Best Quartile | Q1 |
| Total Citations Received (Last 3 Year) |
1572 |
CNS Drugs is a journal published by Adis International Ltd. This journal covers the area[s] related to Neurology (clinical), Pharmacology (medical), Psychiatry and Mental Health, etc.
The coverage history of this journal is as follows: 1994-2022.
The rank of this journal is 2173. This journal's impact score, h-index, and SJR are 5.69, 122, and 1.485, respectively. The ISSN of this journal is/are as follows: 11791934, 11727047.
The best quartile of CNS Drugs is Q1.
This journal has received a total of 1572 citations during the last three years (Preceding 2022).
The latest impact score (IS) of the CNS Drugs is 5.69. It is computed in the year 2023 as per its definition and based on Scopus data.
5.69
It is decreased by a factor of around 0.25, and the percentage change is -4.21% compared to the preceding year 2021, indicating a falling trend.
The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact Score 2022 of CNS Drugs is 5.69. If a similar downward trend continues, IS may decrease in 2023 as well.
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 5.69 |
| 2021 | 5.94 |
| 2020 | 4.66 |
| 2019 | 4.65 |
| 2018 | 4.39 |
| 2017 | 4.61 |
| 2016 | 5.11 |
| 2015 | 5.60 |
| 2014 | 5.77 |
The h-index of CNS Drugs is 122. By definition of the h-index, this journal has at least 122 published articles with more than 122 citations.
The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.
The International Standard Serial Number (ISSN) of CNS Drugs is/are as follows: 11791934, 11727047.
The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.
ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}
The CNS Drugs is ranked 2173 among 27955 Journals, Conferences, and Book Series.
As per SJR, this journal is ranked 1.485.
SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
The publisher of CNS Drugs is Adis International Ltd. The publishing house of this journal is located in the United Kingdom. Its coverage history is as follows: 1994-2022.
Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).
The International Organization for Standardization 4 (ISO 4) abbreviation of CNS Drugs is CNS Drugs. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).
As ISO 4 is an international standard, the abbreviation ('CNS Drugs') can be used for citing, indexing, abstraction, and referencing purposes.
If your area of research or discipline is related to Neurology (clinical), Pharmacology (medical), Psychiatry and Mental Health, etc., please check the journal's official website to understand the complete publication process.
There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:
The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.
The latest impact score of CNS Drugs is 5.69. It is computed in the year 2023.
The latest h-index of CNS Drugs is 122. It is evaluated in the year 2023.
The latest SCImago Journal Rank (SJR) of CNS Drugs is 1.485. It is calculated in the year 2023.
The latest ranking of CNS Drugs is 2173. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.
CNS Drugs is published by Adis International Ltd. The publication country of this journal is United Kingdom.
This standard abbreviation of CNS Drugs is CNS Drugs.
CNS Drugs is a journal published by Adis International Ltd.
The scope of CNS Drugs is as follows:
For detailed scope of CNS Drugs, check the official website of this journal.
The International Standard Serial Number (ISSN) of CNS Drugs is/are as follows: 11791934, 11727047.
The best quartile for CNS Drugs is Q1.
The coverage history of CNS Drugs is as follows 1994-2022.
Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.
| Journal/Conference/Book Title | Type | Publisher | Ranking | SJR | h-index | Impact Score |
|---|---|---|---|---|---|---|
| Journal of Business Economics and Management | Journal | Vilnius Gediminas Technical University | 10343 | 45 | 2.81 | |
| European Union Politics | Journal | SAGE Publications Ltd | 2250 | 72 | 2.64 | |
| Palaeontographica Abteilung B: Palaeophytologie | Book Series | E. Schweizerbart'sche Verlagsbuchhandlung | 15138 | 16 | 2.20 | |
| Biological Procedures Online | Journal | BioMed Central Ltd. | 3350 | 43 | 6.40 | |
| Engenharia Agricola | Journal | Sociedade Brasileira de Engenharia Agricola | 15839 | 30 | 1.12 | |
| European Journal of Wildlife Research | Journal | Springer Verlag | 8709 | 56 | 1.99 | |
| Journal of Evolutionary Psychology | Journal | Akademiai Kiado | 28897 | 0 | 0.00 | |
| Journal on Chain and Network Science | Journal | Wageningen Academic Publishers | 11905 | 24 | 0.00 | |
| International Journal of Advertising | Journal | Taylor and Francis Ltd. | 1226 | 74 | 8.22 | |
| Advanced Studies in Contemporary Mathematics (Kyungshang) (discontinued) | Journal | Jangjeon Mathematical Society | 21650 | 34 | 0.28 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Updated Soon |
| 2022 | 5.69 |
| 2021 | 5.94 |
| 2020 | 4.66 |
| 2019 | 4.65 |
| 2018 | 4.39 |
| 2017 | 4.61 |
| 2016 | 5.11 |
| 2015 | 5.60 |
| 2014 | 5.77 |
5.69
1.485
122
2173
